1. AB0252 Benefit of Sarilumab with csDMARDs on Patient Productivity in Work, Household Work and Family, Social, Leisure Activities in TNF-IR RA Patients. (15th July 2016) Authors: Strand, V.; Mahajan, P.; Chen, C.; van Hoogstraten, H.; Mangan, E.K.; Hagino, O.; Graham, N.; Pinheiro, G.da R.C.; Kivitz, A. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 985 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SAT0174 Efficacy of Sarilumab plus csDMARDs in Rheumatoid Arthritis Patients Who Had An Inadequate Response To One or More than One Prior TNF Inhibitor. (15th July 2016) Authors: Genovese, M.C.; Pinheiro, G.da R.C.; Mangan, E.K.; Lin, Y.; van Adelsberg, J.; van Hoogstraten, H.; Thompson, D.; Fleischmann, R. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 730 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SAT0178 Clinical Responses of Sarilumab Based on Rheumatoid Factor and Anti–Cyclic Citrullinated Peptide Antibody Status in Patients with Rheumatoid Arthritis. (15th July 2016) Authors: Emery, P.; van Hoogstraten, H.; Mangan, E.K.; van Adelsberg, J.; Fan, C.; Kivitz, A.; Pinheiro, G.da R.C.; Huizinga, T. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 732 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗